Key Market Indicators
Israeli insulin imports are projected to climb to approximately $28 million by 2028, up from $25 million in 2023. This represents an annual compound growth rate of 1.4%. Since the year 2000, the demand for insulin in Israel has surged, increasing by an average of 3.6% annually. On the export front, Israel's insulin trade saw a sharp decline. In 2018, insulin exports plummeted to around $14,000, a significant drop from $91,000 in 2017.
